Gaughan R K, Olsen K D, Lewis J E
Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN 55905.
Arch Otolaryngol Head Neck Surg. 1992 Aug;118(8):798-801. doi: 10.1001/archotol.1992.01880080020006.
We reviewed all cases of possible primary squamous cell carcinoma of the parotid gland treated at Mayo Clinic, Rochester, Minn, from 1960 through 1988. Eighteen cases of primary squamous cell carcinoma of the parotid gland were identified. We report the clinical behavior and results of treatment of these rare parotid gland neoplasms. The age at diagnosis ranged from 48 to 86 years; the majority of patients were aged 65 years or older. Half of the patients presented with an asymptomatic parotid gland mass; a painful mass occurred in 33% of patients. Facial paralysis was noted in 17%, and a neck was the presenting symptom in 11% of patients. All patients underwent parotidectomy, and all or part of the facial nerve was sacrificed in 66% of patients. A neck dissection was performed in 12 patients, five of whom had pathologic confirmation of neck metastasis. Adjunctive radiation therapy was performed in 55% of patients. The overall survival at 5 years was 50%. Deep fixation and facial nerve paralysis were associated with a poor prognosis. Most recurrences developed within 1 year of initial treatment. Regional recurrence was always associated with a rapid death. Our data suggest that aggressive treatment and early detection may result in a better prognosis than is commonly associated with these tumors.
我们回顾了1960年至1988年在明尼苏达州罗切斯特市梅奥诊所接受治疗的所有可能的腮腺原发性鳞状细胞癌病例。共确诊18例腮腺原发性鳞状细胞癌。我们报告这些罕见腮腺肿瘤的临床行为及治疗结果。确诊时年龄范围为48岁至86岁;大多数患者年龄在65岁及以上。半数患者表现为无症状腮腺肿块;33%的患者出现疼痛性肿块。17%的患者出现面神经麻痹,11%的患者以颈部症状为首发表现。所有患者均接受了腮腺切除术,66%的患者牺牲了全部或部分面神经。12例患者接受了颈部清扫术,其中5例有颈部转移的病理证实。55%的患者接受了辅助放疗。5年总生存率为50%。肿瘤深部固定和面神经麻痹与预后不良相关。大多数复发发生在初始治疗后的1年内。区域复发总是与快速死亡相关。我们的数据表明,积极治疗和早期发现可能会带来比这些肿瘤通常预后更好的结果。